Pew Supports FDA Efforts to Streamline Regulation of Over-the-Counter Drugs

Pew Supports FDA Efforts to Streamline Regulation of Over-the-Counter Drugs

Pew has sent comments to the Food and Drug Administration supporting its proposal to establish a user fee program to that would help enable faster and more efficient review of the safety and efficacy of listed or proposed ingredients in monographs for over-the-counter drugs. In its Oct. 6 letter, Pew outlined several recommendations aimed at ensuring that FDA has adequate authority, flexibility, and resources to regulate these drug products.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up